Table 2

Multivariable analyses of prognostic factors for survival

ParameterHR95% CIP value
PFS    
 FCR 0.506 0.408-0.628 <.001 
 TK ≥10 U/L 1.362 1.049-1.769 .020 
IGHV-U 1.719 1.326-2.228 <.001 
 11q− 1.546 1.215-1.968 <.001 
 17p− 2.916 1.779-4.781 <.001 
TP53mut 2.123 1.400-3.218 <.001 
SF3B1mut 1.346 1.037-1.747 .026 
OS    
 FCR 0.650 0.480-0.880 .005 
 Age ≥65 y 1.423 1.039-1.950 .028 
 ECOG ≥1 1.622 1.190-2.209 .002 
 β2-MG ≥3.5 mg/L 1.473 1.069-2.030 .018 
 TK ≥10 U/L 1.864 1.195-2.909 .006 
IGHV-U 2.059 1.389-3.053 <.001 
 17p− 2.715 1.602-4.602 <.001 
TP53mut 3.014 1.889-4.808 <.001 
ParameterHR95% CIP value
PFS    
 FCR 0.506 0.408-0.628 <.001 
 TK ≥10 U/L 1.362 1.049-1.769 .020 
IGHV-U 1.719 1.326-2.228 <.001 
 11q− 1.546 1.215-1.968 <.001 
 17p− 2.916 1.779-4.781 <.001 
TP53mut 2.123 1.400-3.218 <.001 
SF3B1mut 1.346 1.037-1.747 .026 
OS    
 FCR 0.650 0.480-0.880 .005 
 Age ≥65 y 1.423 1.039-1.950 .028 
 ECOG ≥1 1.622 1.190-2.209 .002 
 β2-MG ≥3.5 mg/L 1.473 1.069-2.030 .018 
 TK ≥10 U/L 1.864 1.195-2.909 .006 
IGHV-U 2.059 1.389-3.053 <.001 
 17p− 2.715 1.602-4.602 <.001 
TP53mut 3.014 1.889-4.808 <.001 

Variables included in the models: FC, FCR, age, sex, stage, ECOG performance status, CIRS score, B symptoms, white blood cell count, TK, β2-MG, 11q−, +12, 13q−, 17p−, IGHV mutational status, TP53mut, NOTCH1mut, SF3B1mut.

CI, confidence interval; U, unmutated.

Close Modal

or Create an Account

Close Modal
Close Modal